Trying to obtain a clearer understanding of why payers want laterality modifier when it comes to billing Chromotubation (58350). Dye is injected and travels to both tubes so essentially we are reviewing bilaterally. If dye spills, test is good in showing patency. If no spill, test is good in showing blockage. So, essentially, isn't this always a bilateral procedure?